Why should you avoid paring these foods with milk
Milk is a powerhouse of nutrients, but how it's paired with other foods can affect your digestion, metabolism, and overall health. Certain food combinations with milk can create heaviness, fermentation in the gut, and even lead to toxin accumulation, especially according to Ayurveda.
Modern studies also show that some pairings may impact nutrient absorption or gut health. Here's a look at foods you should avoid mixing with milk — and why.
Milk and Citrus Fruits
Citrus fruits like oranges, lemons, and grapefruits contain high levels of ascorbic acid (vitamin C), which can curdle milk upon contact. This curdling not only makes digestion harder but may also reduce protein availability. A study in the Journal of Food Science (2016) noted that acidic conditions significantly affect milk protein stability, potentially leading to indigestion and discomfort.
Milk and Fish
Ayurveda strongly advises against combining milk and fish due to their opposing energies — milk is cooling, while fish is heating. This clash can disturb digestion and lead to skin conditions like rashes or pigmentation. Though modern research is limited, a study published in Ayurveda Journal of Health (2020) supports the traditional belief that this combination may aggravate toxin (ama) production in the body.
by Taboola
by Taboola
Sponsored Links
Sponsored Links
Promoted Links
Promoted Links
You May Like
Brass Krishna Idols For Prosperity & Protection In Life
Luxeartisanship
Shop Now
Undo
Milk and Bananas
Bananas and milk are a popular smoothie combo, but this pairing is considered heavy and mucus-forming. Ayurveda suggests it can disturb digestion and cause sluggishness. Research in the International Journal of Ayurveda and Pharma Research (2018) indicates that such combinations can increase Kapha dosha, leading to sluggish metabolism and sinus-related issues in sensitive individuals.
Milk and Sour Foods (Pickles, Curd)
Sour or fermented foods like yogurt, curd, pickles, or tamarind can curdle milk in the stomach, disrupting digestion.
The acidity alters milk's natural sweetness and protein structure. A study in the Indian Journal of Gastroenterology (2017) highlighted that improper food combinations can lead to dyspepsia and gut inflammation when practiced over time.
Milk and Meat/Eggs
Both milk and animal proteins like meat and eggs are heavy, protein-rich foods. Consuming them together can burden the digestive system, causing incomplete digestion.
A 2015 study in Critical Reviews in Food Science and Nutrition notes that combining complex proteins can delay gastric emptying and hinder nutrient absorption, particularly iron and calcium.
Milk and Salty or Spicy Foods
Combining milk with salty snacks (like namkeen, chips) or spicy items can neutralize milk's cooling effect and disturb digestion. Ayurveda warns this combination can promote ama (toxins) and skin issues. While direct clinical studies are scarce, anecdotal evidence and traditional texts caution against this pairing for skin and gut health.
One step to a healthier you—join Times Health+ Yoga and feel the change
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Time of India
40 minutes ago
- Time of India
Wegovy enters India: Experts discuss health impact of the popular weight loss drug
New Delhi, June 24 (IANS) Danish pharmaceutical company Novo Nordisk on Tuesday launched its once-weekly injectable weight-loss drug Wegovy in India, at Rs 4,336.25 per dose. Weight loss isn't what it used to be. The old 'eat less, move more' mantra just doesn't cut it for many people anymore, especially those dealing with hormonal, genetic, or metabolic roadblocks. Now, a powerful new tool has arrived in India's fight against obesity: Wegovy (semaglutide 2.4mg), the much-discussed weight loss injection that's already made waves in the U.S. and Europe. But is it just another hype-heavy fad, or is it a genuine medical breakthrough? We spoke to some of India's top endocrinologists, gynaecologists, and diabetes specialists—and their answers may surprise you. What is Wegovy? Wegovy is the brand name for a higher-dose formulation of semaglutide, a GLP-1 receptor agonist originally designed to help manage type 2 diabetes. It mimics a hormone that regulates hunger and insulin levels. In simpler terms: it makes you feel full faster, eat less, and burn fat more efficiently—all while improving blood sugar control. And no, it's not a magical skinny shot. But it might be the closest modern science has come to offering one—especially for people with obesity who haven't seen results from diet and exercise alone. India's obesity epidemic: Why Wegovy's arrival matters India is now third globally for obesity and second for type 2 diabetes, according to experts like Dr Muffazal Lakdawala, Director, General Surgery and Minimal Access and Surgical Sciences, Sir H. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất IC Markets Đăng ký Undo N. Reliance Foundation, Hospital, Mumbai, Wegovy represents more than just another prescription drug—it's a mindset shift. 'There is no such thing as 'healthy obesity.' Even when complications are not yet visible, the long-term risks—infertility, cancer, diabetes—are very real,' he says. 'The first step is to view obesity as a disease, not a cosmetic issue.' This change in attitude could finally nudge the Indian public—and policymakers—to take weight seriously. Beyond the kilos: Wegovy's real benefits One of the most impressive things about Wegovy is that its impact goes far beyond the weighing scale. According to Dr. Ambrish Mithal, Chairman & Head of Endocrinology at Max Healthcare, it's not just about dropping a few kilos. 'Semaglutide 2.4mg enhances satiety and also reduces cardiac events by 20% in people with overweight or obesity with pre-existing heart disease,' he explains. 'That's a major breakthrough.' So while narratives may focus on rapid weight loss, doctors are more excited about what's happening inside the body—improved insulin function, reduced inflammation, and even potential neuroprotective benefits, according to Dr. A.G. Unnikrishnan, CEO of Chellaram Diabetes Institute. 'It restores blood-brain barrier integrity and improves astrocyte-vascular interaction,' he says. 'This could be a game-changer for overall metabolic health, not just weight.' A lifeline for diabetics and postpartum women Wegovy may also be a critical lifeline for people with type 2 diabetes and women struggling with postpartum weight gain or PCOS. Dr. Shashank Joshi, a prominent endocrinologist at Lilavati Hospital, explains: 'Semaglutide is valuable for diabetic patients battling obesity. What excites us most is its ability to restore metabolic homeostasis at a cellular level—it's sustainable.' Meanwhile, Dr. Rishma Pai, a top Mumbai-based gynaecologist, highlights how the drug can help break the intergenerational cycle of obesity. 'We see a rising trend of abdominal obesity in women of reproductive age. Around 12-13% of pregnant and postpartum women in India battle obesity. Wegovy, combined with lifestyle changes, can improve maternal health outcomes significantly.' Not a shortcut, but a scientific strategy The word 'weight loss drug' often gets misunderstood—thanks to the many dodgy fat burners that flooded Indian markets in the past. But doctors are clear: Wegovy is not a shortcut. It's science. Dr. V. Mohan, a leading voice in diabetes care, puts it bluntly, 'This is not just about shedding pounds. It addresses the entire obesity-diabetes-metabolic syndrome triad, which is extremely common in Indian patients. We've needed something like this for years.' Experts also see Wegovy as a much-needed alternative to bariatric surgery, especially for patients who aren't eligible or willing to go under the knife. 'It can be an adjunct for those who regain weight post-surgery or an option for those who are ineligible for it,' adds Dr. Lakdawala. So, who should be taking it? Wegovy is not for everyone. It's specifically meant for: Adults with a BMI of 30 or more (obese) Adults with a BMI of 27 or more who also have weight-related health problems like high blood pressure, type 2 diabetes, or high cholesterol It's not a vanity drug. It's a prescription-only, doctor-supervised therapy that needs to be part of a broader weight loss plan that includes a balanced diet and regular movement. Risks and realities Like any drug, Wegovy isn't side-effect-free. Nausea, vomiting, constipation, and headaches are some of the commonly reported issues—especially in the early weeks. And it's not a magic wand. Once you stop taking it, the weight may come back unless long-term lifestyle changes are in place. That's why all doctors stress the importance of pairing the drug with behavioural support and nutritional guidance. "Anti-obesity medications like Wegovy must be evaluated not merely by percentage weight loss, but by their ability to change hard clinical outcomes — reducing CVD, CKD, and potentially extending life. It's time we see these therapies as tools for longevity and disease prevention, not just for the weighing scale," says Dr. Rajiv Kovil, Head of Diabetology, Zandra Healthcare, and Co-founder of Rang De Neela Initiative. India has long treated obesity as a willpower problem rather than a medical condition. Wegovy's arrival could finally change that. If used wisely—and accessibly—Wegovy could be more than just a drug. It could be India's long-overdue wake-up call to treat obesity as the serious, system-wide condition that it truly is. Wegovy is finally in India. It's not a fad, but a clinically proven weight-loss injection that tackles metabolic dysfunction, improves heart health, and might help people with diabetes, PCOS, and obesity live better, longer lives. But it's no solo act—healthy lifestyle habits still lead the show. One step to a healthier you—join Times Health+ Yoga and feel the change
Time of India
3 hours ago
- Time of India
Game-changer HIV shot approved in US may enter Canada by 2026; Just two injections a year
A twice-a-year injectable drug being hailed as a breakthrough in HIV prevention could be available in Canada as early as mid-2026, offering new hope in the fight against the virus. The drug, lenacapavir , developed by Gilead Sciences , was approved by the US Food and Drug Administration (FDA) last week for pre-exposure prophylaxis (PrEP). It is the first and only HIV prevention medication that requires just two doses per year. Gilead Canada submitted the drug to Health Canada in April for review, which was accepted earlier this month. Lenacapavir was approved in Canada in 2022 for treatment, but this is the first time it's under review for prevention. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Free P2,000 GCash eGift UnionBank Credit Card Apply Now Undo 'This is absolutely a monumental advance in prevention,' said Peter Newman, a professor at the University of Toronto whose work focuses on HIV prevention. 'It's certainly cost-effective in the long run because you're going to prevent a lot of cases of new HIV.' How does it work Live Events Lenacapavir works by creating a slow-release 'depot' of medicine under the skin, delivering protection for six months. Clinical trials showed near-total effectiveness: among more than 2,000 high-risk women in Africa, zero new infections were recorded. In another trial among gay and bisexual men and transgender women, only two infections occurred, both in participants who were already HIV-positive before the injection. Very expensive Gilead's US list price is $28,218 a year, sparking concerns about access and affordability, especially for marginalized groups. 'We could get a lot of interest, but if people can't afford it, it's dead in the water,' O'Byrne said. Currently in Canada, 54 percent of PrEP prescriptions are paid for by private insurance and 43 percent by public programs, according to the Public Health Agency of Canada. Gilead says it will work with both public and private payers to 'accelerate availability and access.' If approved, the shot will only be available through healthcare providers, doctors, or nurses. But experts argue it should be expanded to include pharmacists and nurse practitioners, especially to increase access in remote or underserved areas.
Time of India
3 hours ago
- Time of India
AI 171 crash: 260 deaths confirmed, verification still on: Gujarat health minister
1 2 Ahmedabad: Rushikesh Patel, the state health minister said that 260 people have been confirmed dead till Tuesday in the Air India 171 plane crash incident even as further verification process is ongoing. "Some verification work is still ongoing, but so far 260 deaths have been confirmed by DNA match and other methods along with police verification," said Patel. Govt sources said that it could take a couple of more days before the final casualty can be ascertained based on scientific evidence. Health department officials said that the 260 confirmed dead so far include 241 passengers and crew onboard the ill-fated flight and 19 confirmed deaths on ground due to impact and subsequent fireball where the temperature soared to about 1,000°C. Sources said that the actual figure of the deaths in the incident will only be confirmed after completion of the DNA match process. You Can Also Check: Ahmedabad AQI | Weather in Ahmedabad | Bank Holidays in Ahmedabad | Public Holidays in Ahmedabad "Till Tuesday, 259 persons who died in the crash have been identified. These include 240 persons aboard the AI 171 along with 13 persons who died on the ground who were identified using DNA match. Six other persons who died on the ground were identified by their kin based on their physical and facial features," said Dr Rakesh Joshi, medical superintendent of the Civil Hospital, Ahmedabad which is coordinating the handing over of mortal remains of the plane crash victims to the relatives. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Giao dịch vàng CFDs với mức chênh lệch giá thấp nhất IC Markets Đăng ký Undo Health department officials said that till Tuesday, DNA match for one of the 241 passengers remains to be ascertained. Sources said a few samples continue to remain with the Gandhinagar-based forensic laboratories in highly charred condition. "Forensic experts are attempting to extract the DNA using advanced methods," said a source. Meanwhile, Civil Hospital authorities handed over mortal remains of a UK resident on Tuesday, taking the number of handed-over bodies from the crash to 257. Dr Joshi said that two bodies remain with the authorities and both are UK nationals. "They are likely to be sent home soon for the last rites," he said. All 60 passengers with foreign nationalities including 52 from the UK, seven from Portugal, and one from Canada have been identified and 58 of them have been sent home, said officials. Among the Indian nationals, the highest death toll is recorded for Ahmedabad at 73. Noel Tata visits crash site, patients in Ahmedabad Ahmedabad: Tata Trusts chairman Noel Tata made a brief visit to Ahmedabad on Tuesday in the aftermath of the Air India 171 plane crash on June 12. Tata is reported to have visited the airplane crash site in Meghaninagar, patients admitted at the Civil Hospital, and city police commissioner GS Mallik. Confirming Tata's visit, Mallik said that it was a courtesy call following the plane crash tragedy. "He thanked the city police for their work following the crash and appreciated our commitment," said Mallik, adding it was an informal visit. Sources at the airport said that Tata arrived at the General Aviation terminal of Sardar Vallabhbhai Patel International Airport (SVPI) around 7am and departed by 2pm the same day, via chartered aircraft. Officials at Civil Hospital confirmed that a Tata-group delegation visited the hospital on Tuesday. "The delegation discussed the crash incident, the hospital's response to the incident and the health of injured victims," a senior official of the hospital said. BJMC fraternity pays homage to deceased students Ahmedabad: On Tuesday, 12 days after the devastating air crash on the mess of the BJ Medical College, the BJ Medical College fraternity paid homage to the four medical students and other victims of the AI 171 airplane crash. The prayer meet was attended by state health minister Rushikesh Patel, along with senior health department officials, Civil Hospital staff, students and tutors, and relatives of the deceased. The senior officials also planted trees on the medical college campus as a remembrance of the deceased students. About 25 persons, several of them medical students, were also injured in the crash. The majority of them have recuperated and joined duty, said officials.
